Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Stephan Blinder"'
Autor:
Alexander Thiel, Alexey Kostikov, Hailey Ahn, Youstina Daoud, Jean-Paul Soucy, Stephan Blinder, Carolin Jaworski, Carmen Wängler, Björn Wängler, Freimut Juengling, Shirin A. Enger, Ralf Schirrmacher
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 8, Iss 1, Pp 1-9 (2023)
Abstract Background Reduced expression or impaired signalling of tropomyosin receptor kinases (Trk receptors) are found in a vast spectrum of CNS disorders. [18F]TRACK is the first PET radioligand for TrkB/C with proven in vivo brain penetration and
Externí odkaz:
https://doaj.org/article/c2a2926d0215420eb0000e3e6b42c40c
Autor:
Min Su Kang, Alexander Thiel, Ralf Schirrmacher, Vadim Bernard‐Gauthier, Carolin Jaworski, Andreas Dorian, Robert Hopewell, Thomas A Singleton, Stephan Blinder, Jean‐Paul Soucy, Pedro Rosa‐Neto, Alexey Kostikov
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Andrew K. H. Robertson, Stephan Blinder, Cristina Rodríguez-Rodríguez, Vesna Sossi, Peter Kunz, Caterina F. Ramogida, Paul Schaffer
Publikováno v:
Physics in Medicine and Biology. 62:4406-4420
Effective use of the decay chain in targeted internal radioimmunotherapy requires the retention of both and progeny isotopes at the target site. Imaging-based pharmacokinetic tests of these pharmaceuticals must therefore separately yet simultaneously
Autor:
Mihaela Boca, Robert B. Harrison, Chris Boiko, Max Woolley, Suk Kinch, David W. Johnson, Matthias Luz, Steven S Gill, Erich Mohr, Neil U Barua, Greg A. Johnson, David Cronin, H. Christian Fibiger, Gemma Pritchard, A. Jon Stoessl, Owen T. Lewis, Alan L Whone, Andrew D. Lawrence, Michael Howell, C. Irving, Lucy Mooney, C Lynn Barclay, Christopher Marshall, Sonali Dharia, Jack Broadfoot, Paul Skinner, Lara Longpre, Stephan Blinder, Vesna Sossi, Christian Schroers
Publikováno v:
Journal of Parkinson's Disease
Whone, A L, Boca, M, Luz, M, Woolley, M, Mooney, L, Dharia, S, Broadfoot, J, Cronin, D, Schroers, C, Barua, N U, Longpre, L, Barclay, C L, Boiko, C, Johnson, G A, Fibiger, H C, Harrison, R, Lewis, O, Pritchard, G, Howell, M, Irving, C, Johnson, D, Kinch, S, Marshall, C, Lawrence, A D, Blinder, S, Sossi, V, Stoessl, A J, Skinner, P, Mohr, E & Gill, S S 2019, ' Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease ', Journal of Parkinson's Disease, vol. 9, no. 2, pp. 301-313 . https://doi.org/10.3233/JPD-191576
Whone, A L, Boca, M, Luz, M, Woolley, M, Mooney, L, Dharia, S, Broadfoot, J, Cronin, D, Schroers, C, Barua, N U, Longpre, L, Barclay, C L, Boiko, C, Johnson, G A, Fibiger, H C, Harrison, R, Lewis, O, Pritchard, G, Howell, M, Irving, C, Johnson, D, Kinch, S, Marshall, C, Lawrence, A D, Blinder, S, Sossi, V, Stoessl, A J, Skinner, P, Mohr, E & Gill, S S 2019, ' Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease ', Journal of Parkinson's Disease, vol. 9, no. 2, pp. 301-313 . https://doi.org/10.3233/JPD-191576
BACKGROUND: Intraputamenal glial cell line-derived neurotrophic factor (GDNF), administered every 4 weeks to patients with moderately advanced Parkinson's disease, did not show significant clinical improvements against placebo at 40 weeks, although i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b091e1f3509da254e4bc378589c5ff6
https://orca.cardiff.ac.uk/id/eprint/121770/1/untitled.pdf
https://orca.cardiff.ac.uk/id/eprint/121770/1/untitled.pdf
Autor:
Steven Staelens, Alan Miranda, Min Su Kang, Arturo Aliaga-Aliaga, Stephan Blinder, Jean-Paul Soucy, Jeroen Verhaeghe, Reda Bouhachi, Sigrid Stroobants, Pedro Rosa-Neto, Gassan Massarweh
Publikováno v:
Neuroimage
Awake rat brain positron emission tomography (PET) has previously been developed to avoid the influence of anesthesia on the rat brain response. In the present work, we further the awake rat brain scanning methodology to establish simultaneous scanni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d38d6d96e60e92faddac00bcb15401
https://zenodo.org/record/3232921
https://zenodo.org/record/3232921
Autor:
Suk Kinch, Steven S Gill, Chris Boiko, Christian Schroers, C. Irving, C Lynn Barclay, David W. Johnson, Neil U Barua, Stephan Blinder, Michael Howell, Sonali Dharia, Lara Longpre, Paul Skinner, Robert B. Harrison, Jack Broadfoot, Erich Mohr, Alan L Whone, Mihaela Boca, A. Jon Stoessl, Owen T. Lewis, Andrew D. Lawrence, Lucy Mooney, Greg A. Johnson, David Cronin, Vesna Sossi, Matthias Luz, Max Woolley, Christopher Marshall, H. Christian Fibiger, Gemma Pritchard
Publikováno v:
Whone, A, Luz, M, Boca, M, Woolley, M, Mooney, L, Dharia, S, Broadfoot, J, Cronin, D, Schroers, C, Barua, N U, Longpre, L, Barclay, C L, Boiko, C, Johnson, G A, Fibiger, H C, Harrison, R, Lewis, O, Pritchard, G, Howell, M, Irving, C, Johnson, D, Kinch, S, Marshall, C, Lawrence, A D, Blinder, S, Sossi, V, Stoessl, A J, Skinner, P, Mohr, E & Gill, S S 2019, ' Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease ', Brain, vol. 142, no. 3, pp. 512-525 . https://doi.org/10.1093/brain/awz023
Brain
Brain
Trials of GDNF in Parkinson’s disease have yielded inconsistent results. In a randomised controlled trial, Whone et al. administer GDNF using a paradigm designed to optimize delivery to the putamen. [18F]DOPA PET reveals putamen-wide uptake, but GD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6226e493a07ede7db09cf05c8b8daf5
https://research-information.bris.ac.uk/ws/files/196865531/Full_text_PDF_final_published_version_.pdf
https://research-information.bris.ac.uk/ws/files/196865531/Full_text_PDF_final_published_version_.pdf
Autor:
A K H, Robertson, C F, Ramogida, C, Rodríguez-Rodríguez, Stephan, Blinder, Peter, Kunz, Vesna, Sossi, Paul, Schaffer
Publikováno v:
Physics in medicine and biology. 62(11)
Effective use of the [Formula: see text] decay chain in targeted internal radioimmunotherapy requires the retention of both [Formula: see text] and progeny isotopes at the target site. Imaging-based pharmacokinetic tests of these pharmaceuticals must
Autor:
Marlies C Goorden, Freek J. Beekman, Ruud M. Ramakers, Frans van der Have, Katherine Dinelle, Maryam Shirmohammad, Matthew D. Walker, Vesna Sossi, Stephan Blinder
Publikováno v:
Journal of Nuclear Medicine. 55:1368-1374
PET imaging of rodents is increasingly used in preclinical research, but its utility is limited by spatial resolution and signal-to-noise ratio of the images. A recently developed preclinical PET system uses a clustered-pinhole collimator, enabling h
Publikováno v:
Medical Physics. 39:5073-5083
Purpose: The Siemens ECAT high resolution research tomograph (HRRT) is a dedicated human brainPETcamera with a 6% absolute sensitivity and a (2.3 mm)3spatial resolution, improving to (1.8 mm)3 when point spread function (PSF) modeling algorithms are
Publikováno v:
Medical Physics. 38:773-781
Purpose: Subject motion during positron emission tomography(PET)brain scans can reduce image quality and may lead to incorrect biological outcome measures, especially for data acquired with high resolution tomographs. A semiautomatic method for asses